Mass General Hospital develops clinical decision support tool for mpox diagnosis

FHS
April 5, 2024
7:02 pm

Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there’s limited clinical experience.

Ipsen gains global rights to Foreseen Biotechnology’s FS001 ADC

FS001 incorporates a stable and cleavable linker with a potent topoisomerase I inhibitor. Credit: 15Studio/Shutterstock. Ipsen has entered an exclusive global licensing agreement with Foreseen

July 12, 2024

Biogen signs molecular glue deal, raises yearly projections

Is 2024 the year of molecular glues? Biogen on Tuesday became the latest company to partner on the increasingly popular subject, teaming up with private

October 31, 2024

No Change in Huntington’s Motor Symptoms With Investigational Drug

Investigational laquinimod did not change motor symptoms of Huntington’s disease after 1 year but did significantly reduce caudate volume loss compared with placebo, the phase

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.